Lexaria Bioscience Corp. (NASDAQ:LEXXW) Sees Significant Growth in Short Interest

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 2,400 shares, a growth of 20.0% from the February 28th total of 2,000 shares. Based on an average trading volume of 10,800 shares, the short-interest ratio is presently 0.2 days.

Lexaria Bioscience Price Performance

Shares of NASDAQ LEXXW traded down $0.09 on Thursday, hitting $0.21. The company had a trading volume of 300 shares, compared to its average volume of 12,279. Lexaria Bioscience has a 12-month low of $0.16 and a 12-month high of $2.00. The business has a 50 day moving average of $0.31 and a two-hundred day moving average of $0.62.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.